1h Free Analyst Time
The publisher has been monitoring the pharmacokinetics services market and it is poised to grow by $360.03 million during 2021-2025, progressing at a CAGR of 7.66% during the forecast period. The report on the pharmacokinetics services market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing attrition rate of therapeutic drugs in clinical trials and growing R&D expenditure in the pharmaceutical & biopharmaceutical industry.
The pharmacokinetics services market analysis includes the type segment and geographic landscape.
The pharmacokinetics services market is segmented as below:
By Type
- Small molecules
- Large molecules
By Geographic
- North America
- Europe
- Asia
- ROW
This study identifies the initiatives for research on rare diseases and orphan drugs as one of the prime reasons driving the pharmacokinetics services market growth during the next few years.
The report on pharmacokinetics services market covers the following areas:
- Pharmacokinetics services market sizing
- Pharmacokinetics services market forecast
- Pharmacokinetics services market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmacokinetics services market vendors that include Certara Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Evotec SE, Frontage Holdings Corp., LGC Ltd., Pacific BioLabs Inc., Parexel International Corp., PPD Inc., and SGS SA. Also, the pharmacokinetics services market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Type
- Market segments
- Comparison by Type
- Small molecules - Market size and forecast 2020-2025
- Large molecules - Market size and forecast 2020-2025
- Market opportunity by Type
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Certara Inc.
- Charles River Laboratories International Inc.
- Eurofins Scientific SE
- Evotec SE
- Frontage Holdings Corp.
- LGC Ltd.
- Pacific BioLabs Inc.
- Parexel International Corp.
- PPD Inc.
- SGS SA
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2020 - 2025 ($ million)
- Global market: Year-over-year growth 2020 - 2025 (%)
- Five forces analysis 2020 & 2025
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2020
- Type - Market share 2020-2025 (%)
- Comparison by Type
- Small molecules - Market size and forecast 2020-2025 ($ million)
- Small molecules - Year-over-year growth 2020-2025 (%)
- Large molecules - Market size and forecast 2020-2025 ($ million)
- Large molecules - Year-over-year growth 2020-2025 (%)
- Market opportunity by Type
- Customer landscape
- Market share By Geographical Landscape 2020-2025 (%)
- Geographic comparison
- North America - Market size and forecast 2020-2025 ($ million)
- North America - Year-over-year growth 2020-2025 (%)
- Europe - Market size and forecast 2020-2025 ($ million)
- Europe - Year-over-year growth 2020-2025 (%)
- Asia - Market size and forecast 2020-2025 ($ million)
- Asia - Year-over-year growth 2020-2025 (%)
- ROW - Market size and forecast 2020-2025 ($ million)
- ROW - Year-over-year growth 2020-2025 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Certara Inc. - Overview
- Certara Inc. - Product and service
- Certara Inc. - Key offerings
- Certara Inc. - Key customers
- Certara Inc. - Segment focus
- Charles River Laboratories International Inc. - Overview
- Charles River Laboratories International Inc. - Business segments
- Charles River Laboratories International Inc. - Key offerings
- Charles River Laboratories International Inc. - Key customers
- Charles River Laboratories International Inc. - Segment focus
- Eurofins Scientific SE - Overview
- Eurofins Scientific SE - Business segments
- Eurofins Scientific SE - Key offerings
- Eurofins Scientific SE - Key customers
- Eurofins Scientific SE - Segment focus
- Evotec SE - Overview
- Evotec SE - Business segments
- Evotec SE - Key offerings
- Evotec SE - Key customers
- Evotec SE - Segment focus
- Frontage Holdings Corp. - Overview
- Frontage Holdings Corp. - Business segments
- Frontage Holdings Corp. - Key offerings
- Frontage Holdings Corp. - Key customers
- Frontage Holdings Corp. - Segment focus
- LGC Ltd. - Overview
- LGC Ltd. - Product and service
- LGC Ltd. - Key offerings
- LGC Ltd. - Key customers
- LGC Ltd. - Segment focus
- Pacific BioLabs Inc. - Overview
- Pacific BioLabs Inc. - Product and service
- Pacific BioLabs Inc. - Key offerings
- Pacific BioLabs Inc. - Key customers
- Pacific BioLabs Inc. - Segment focus
- Parexel International Corp. - Overview
- Parexel International Corp. - Product and service
- Parexel International Corp. - Key offerings
- Parexel International Corp. - Key customers
- Parexel International Corp. - Segment focus
- PPD Inc. - Overview
- PPD Inc. - Product and service
- PPD Inc. - Key offerings
- PPD Inc. - Key customers
- PPD Inc. - Segment focus
- SGS SA - Overview
- SGS SA - Business segments
- SGS SA - Key offerings
- SGS SA - Key customers
- SGS SA - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global pharmacokinetics services market: Certara Inc., Charles River Laboratories International Inc., Eurofins Scientific SE, Evotec SE, Frontage Holdings Corp., LGC Ltd., Pacific BioLabs Inc., Parexel International Corp., PPD Inc., and SGS SA.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is initiatives for research on rare diseases and orphan drugs.'
According to the report, one of the major drivers for this market is the increasing attrition rate of therapeutic drugs in clinical trials.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Certara Inc.
- Charles River Laboratories International Inc.
- Eurofins Scientific SE
- Evotec SE
- Frontage Holdings Corp.
- LGC Ltd.
- Pacific BioLabs Inc.
- Parexel International Corp.
- PPD Inc.
- SGS SA
